Previous 10 | Next 10 |
EMERYVILLE, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health” or “Lucira”), a medical technology company, today announced interim results of a pilot study to evaluate the performance of their combined Chlamydia trach...
EMERYVILLE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, and a digit...
Gainers: Artelo Biosciences ( ARTL ) +31% . Ventyx Biosciences ( VTYX ) +23% . Eargo ( EAR ) +19% . Fulcrum Therapeutics ( FULC ) +18% . Genprex ( GNPX ) +17% . Losers: Albireo Pharma ( ALBO ) -25% . Sema4...
Lucira Health, Inc. (LHDX) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET Company Participants Louisa Smith – Investor Relations Erik Engelson – President and Chief Executive Officer Dan George – Chief Financial Officer and Treas...
Image source: The Motley Fool. Lucira Health, Inc. (NASDAQ: LHDX) Q2 2022 Earnings Call Aug 15, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Lucira Health, Inc. (LHDX) Q2 2022 Earnings Call Transcript
Lucira Health press release ( NASDAQ: LHDX ): Q2 GAAP EPS of $0.54 beats by $0.93 . Revenue of $26.1M (+109.8% Y/Y) misses by $2.33M . Cash and Cash Equivalents Balance as of June 30, 2022 was $75.0 million. For further details see: Lucira Hea...
EMERYVILLE, Calif., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today reported fina...
Lucira Health ( NASDAQ: LHDX ) said Health Canada granted authorization for emergency use and commercialization of the company's at-home test for COVID and Flu. The Lucira COVID-19 & Flu Test is a 99% accurate rapid molecular test which delivers results in 30 ...
EMERYVILLE, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease tests, today announced tha...
EMERYVILLE, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced t...
News, Short Squeeze, Breakout and More Instantly...
Lucira Health Inc. Company Name:
LHDX Stock Symbol:
NASDAQ Market:
Why Liquidity and Volume Are Important for Trading Penny Stocks Penny stocks are a popular investment choice for traders due to their low price and potential for high returns. However, trading penny stocks can be risky, especially if the trader is not well-informed about the market. In th...